Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
About Us 
Home / About Us / News
News 
2021-02-26
TW Patent No. I718533 entitled PREPARATION METHOD OF RIBOCICLIB AND ITS SALT AND CRYSTALLINE FORM THEREOF was granted on Feb 11, 2021.
2021-01-05
Filed US DMF of Ferric Carboxymaltose (#035442, date of submission: Dec. 31, 2020)
2021-01-05
Filed US DMF of Eribulin Mesylate (#035358, date of submission: Nov. 30, 2020)
2020-09-30
US Patent No.US10766900B2 entitled Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof was granted on Sep 8, 2020.
2020-09-14
Filed CN DMF of Gadoterate Meglumine (#Y20200000802, date of submission: Sep. 14, 2020)
2020-09-01
TW Patent No. I703163 entitled Method for preparing Sugammadex Sodium and crystalline form thereof was granted on Sep 1, 2020.
2020-07-03
Filed US DMF of Elagolix Sodium (#034907, date of submission: Jun. 30, 2020)
2020-05-12
US Patent No.US10626110B2 entitled Polymorph of Pazopanib Hydrochloride and preparation process thereof was granted on April 21, 2020.
2020-04-21
Filed JP DMF of Alfacalcidol (#302MF10045, date of submission:Apr. 10, 2020)

 

 

 

 
Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.
丙肝